Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Introduction: Acute kidney injury (AKI) is a frequent complication of cardiopulmonary bypass (CPB). The lack of early biomarkers has impaired our ability to intervene in a timely manner. We previously showed in a small cohort of patients that plasma neutrophil gelatinase-associated lipocalin (NGAL), measured using a research enzyme-linked immunosorbent assay, is an early predictive biomarker of AKI after CPB. In this study we tested whether a point-of-care NGAL device can predict AKI after CPB in a larger cohort. Methods: First, in a cross-sectional pilot study including 40 plasma samples (NGAL range 60 to 730 ng/ml) and 12 calibration standards (NGAL range 0 to 1,925 ng/ml), NGAL measurements by enzyme-linked immunosorbent assay and by Triage® NGAL Device (Biosite Inc., San Diego, CA, USA) were highly correlated (r = 0.94). Second, in a subsequent prospective uncontrolled cohort study, 120 children undergoing CPB were enrolled. Plasma was collected at baseline and at frequent intervals for 24 hours after CPB, and analyzed for NGAL using the Triage® NGAL device. The primary outcome was AKI, which was defined as a 50% or greater increase in serum creatinine. Results: AKI developed in 45 patients (37%), but the diagnosis using serum creatinine was delayed by 2 to 3 days after CPB. In contrast, mean plasma NGAL levels increased threefold within 2 hours of CPB and remained significantly elevated for the duration of the study. By multivariate analysis, plasma NGAL at 2 hours after CPB was the most powerful independent predictor of AKI (β = 0.004, P < 0.0001). For the 2-hour plasma NGAL measurement, the area under the curve was 0.96, sensitivity was 0.84, and specificity was 0.94 for prediction of AKI using a cut-off value of 150 ng/ml. The 2 hour postoperative plasma NGAL levels strongly correlated with change in creatinine (r = 0.46, P < 0.001), duration of AKI (r = 0.57, P < 0.001), and length of hospital stay (r = 0.44, P < 0.001). The 12-hour plasma NGAL strongly correlated with mortality (r = 0.48, P = 0.004) and all measures of morbidity mentioned above. Conclusion: Accurate measurements of plasma NGAL are obtained using the point-of-care Triage® NGAL device. Plasma NGAL is an early predictive biomarker of AKI, morbidity, and mortality after pediatric CPB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The finding that NGAL was one of the most highly expressed proteins following ischaemia-reperfusion injury in kidney cells [372-374], and prognostic of kidney damage long before the more traditional marker creatinine was raised significantly, has led to considerable interest in this protein, especially as a marker of renal injury [375-389]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M. M., Ma, Q., Kelly, C., Ruff, S. M., Zahedi, K., Shao, M., Bean, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74811-x · Cited by 2,394 · cited 5×
“A major reason for the failure to find an effective treatment in patients is the paucity of early biomarkers for AKI, akin to troponins in acute myocardial disease, and hence a delay in initiating therapy [ 16 ].”
InfluentialSelf-citationMishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088027.54400.c6 · Cited by 1,749
Self-citationLassnigg, A., Schmidlin, D., Mouhieddine, M., Bachmann, L. M., Druml, W., Bauer, P., & Hiesmayr, M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130340.93930.dd · Cited by 1,348 · cited 1×
“minor degrees of postoperative AKI, as manifest by only a 0.2 to 0.3 mg/dl rise in serum creatinine from baseline, predict a significant increase in short-term mortality [ 5 ,6].”
BackgroundInfluentialIndependent Association between Acute Renal Failure and Mortality following Cardiac Surgery
Chertow, G. M., Levy, E. M., Hammermeister, K. E., Grover, F., & Daley, J. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00058-8 · Cited by 1,177 · cited 1×
“9 [4].”
Mangano, C. M., Diamondstone, L. S., Ramsay, J. G., Aggarwal, A., Herskowitz, A., & Mangano, D. T. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00005 · Cited by 1,086
A Clinical Score to Predict Acute Renal Failure after Cardiac Surgery
Thakar, C. V., Arrigain, S., Worley, S., Yared, J.-P., & Paganini, E. P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004040331 · Cited by 1,067 · cited 1×
“Clinical investigations have identified several risk factors associated with the development of AKI after CPB, the majority related to either impaired renal perfusion or decreased renal reserve, and have resulted in the development of clinical scoring systems for the prediction of AKI [10-13].”
BackgroundAcute Kidney Injury Associated with Cardiac Surgery
Rosner, M. H., & Okusa, M. D. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240605 · Cited by 1,063 · cited 1×
“Acute kidney injury (AKI), previously referred to as acute renal failure, is a frequent and serious complication encountered in 30% to 50% of subjects after CPB [2,3].”
BackgroundUpdate on Mechanisms of Ischemic Acute Kidney Injury
Devarajan, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010017 · Cited by 1,026 · cited 1×
“sciences have illuminated the pathogenesis of AKI and have paved the way to successful therapeutic approaches in animal models [14].”
BackgroundSelf-citationMori, K., Lee, H. T., Rapoport, D., Drexler, I. R., Foster, K., Yang, J., Schmidt-Ott, K. M., Chen, X., Li, J. Y., Weiss, S., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23056 · Cited by 954
Self-citation
Cited by
Haase, M., Bellomo, R., Devarajan, P., Schlattmann, P., & Haase-Fielitz, A. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.07.020 · Cited by 1,339
“Of enrolled patients, 70% were rom the United States.(13-16,18,19,22,23,25,26) Alhough there were 2 studies from China(20,28) and from South America,(27) the generalizability of GAL value needs further local investigation nd validation.”
BackgroundMethodSelf-citationCardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment
Wang, Y., & Bellomo, R. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.119 · Cited by 767
Zuk, A., & Bonventre, J. V. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-050214-013407 · Cited by 739
Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery
Parikh, C. R., Coca, S. G., Thiessen-Philbrook, H., Shlipak, M. G., Koyner, J. L., Wang, Z., Edelstein, C. L., Devarajan, P., Patel, U. D., Zappitelli, M., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121302 · Cited by 754
Self-citationThe Outcome of Neutrophil Gelatinase-Associated Lipocalin-Positive Subclinical Acute Kidney Injury
Haase, M., Devarajan, P., Haase-Fielitz, A., Bellomo, R., Cruz, D. N., Wagener, G., Krawczeski, C. D., Koyner, J. L., Murray, P., Zappitelli, M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.051 · Cited by 684
“It was iscovered with unbiased transcriptomic approaches (8,9); it s rapidly induced and released from the injured distal ephron in experimental models and human disease 5,9,10); its urine and plasma concentrations increase proortionally to severity and duration of renal injury (9,11,12); ts concentration rapidly decr…”
BackgroundSelf-citationUrinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery
Parikh, C. R., Mishra, J., Thiessen-Philbrook, H., Dursun, B., Ma, Q., Kelly, C., Dent, C., Devarajan, P., & Edelstein, C. L. (2006) · Kidney International · doi:10.1038/sj.ki.5001527 · Cited by 608
Self-citationKell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“renal injury [375-389], and perhaps as a therapeutic”
BackgroundLi, S., Krawczeski, C. D., Zappitelli, M., Devarajan, P., Thiessen-Philbrook, H., Coca, S. G., Kim, R. W., & Parikh, C. R. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821201d3 · Cited by 483
Self-citationBiomarkers in chronic kidney disease: a review
Fassett, R. G., Venuthurupalli, S. K., Gobe, G. C., Coombes, J. S., Cooper, M. A., & Hoy, W. E. (2011) · Kidney International · doi:10.1038/ki.2011.198 · Cited by 449
Biomarkers in acute kidney injury – pathophysiological basis and clinical performance
Schrezenmeier, E. V., Barasch, J., Budde, K., Westhoff, T., & Schmidt‐Ott, K. M. (2017) · Acta Physiologica · doi:10.1111/apha.12764 · Cited by 401
“It has shown its performance in various settings such as the prediction of AKI in paediatric (Dent et al. 2007) and adult cardiac surgery patients (Parikh et al.”
BackgroundSelf-citationCongenital heart surgery in infants: Effects of acute kidney injury on outcomes
Blinder, J. J., Goldstein, S. L., Lee, V.-V., Baycroft, A., Fraser, C. D., Nelson, D., & Jefferies, J. L. (2012) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.06.021 · Cited by 418
“Like previous investigators, we found that the need for CPB during surgical intervention was independently associated with postoperative AKI.(7,11,17,18) When we treated CPB as an ordinal variable, we found that longer CPB time was associated with greater odds of postoperative AKI.”
Biomarkers of renal function, which and when?
Wasung, M. E., Chawla, L. S., & Madero, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.039 · Cited by 374
“In the study conducted by Siew and colleagues [32], urinary elevations of IL-18 did not predict AKI, but did predict poor outcomes such as death and the need for short term dialysis.”
BackgroundVanmassenhove, J., Vanholder, R., Nagler, E., & Van Biesen, W. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs380 · Cited by 377
Neutrophil gelatinase‐associated lipocalin (NGAL): A new marker of kidney disease
Devarajan, P. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802150158 · Cited by 378
Self-citationAlkandari, O., Eddington, K. A., Hyder, A., Gauvin, F., Ducruet, T., Gottesman, R., Phan, V., & Zappitelli, M. (2011) · Critical Care · doi:10.1186/cc10269 · Cited by 359
“A voluminous amount of research has been devoted to early AKI detection by using novel biomarkers of AKI [17-21], since SCr is thought to increase late with AKI and, for AKI treatments to be successful, early biomarker application is necessary [22,23].”
BackgroundDEVARAJAN, P. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01317.x · Cited by 356
Self-citationParikh, C. R., Devarajan, P., Zappitelli, M., Sint, K., Thiessen-Philbrook, H., Li, S., Kim, R. W., Koyner, J. L., Coca, S. G., Edelstein, C. L., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111163 · Cited by 351
“0001 median (IQR) 2 (1, 4) 5 (3, 8) 2 (1, 3) length of hospital stay (days), mean (SD) 8.”
Self-citationCruz, D. N., de Cal, M., Garzotto, F., Perazella, M. A., Lentini, P., Corradi, V., Piccinni, P., & Ronco, C. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1711-1 · Cited by 347
Neutrophil Gelatinase-Associated Lipocalin: A� Promising Biomarker for Human Acute Kidney Injury
Devarajan, P. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.12 · Cited by 332
Self-citationZappitelli, M., Bernier, P.-L., Saczkowski, R. S., Tchervenkov, C. I., Gottesman, R., Dancea, A., Hyder, A., & Alkandari, O. (2009) · Kidney International · doi:10.1038/ki.2009.270 · Cited by 331
Bagshaw, S. M., Bennett, M., Haase, M., Haase-Fielitz, A., Egi, M., Morimatsu, H., D’amico, G., Goldsmith, D., Devarajan, P., & Bellomo, R. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1724-9 · Cited by 328
“, San Diego, CA), a pointof-care, fluorescence immunoassay for quantitative measurement of pNGAL, as previously described [27].”
Self-citationAcute Kidney Injury Reduces Survival in Very Low Birth Weight Infants
Koralkar, R., Ambalavanan, N., Levitan, E. B., McGwin, G., Goldstein, S., & Askenazi, D. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e31820b95ca · Cited by 314
Biomarkers for the early detection of acute kidney injury
Devarajan, P. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328343f4dd · Cited by 284
Self-citationMårtensson, J., Bell, M., Oldner, A., Xu, S., Venge, P., & Martling, C.-R. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1887-4 · Cited by 294
The Origin of Multiple Molecular Forms in Urine of HNL/NGAL
Cai, L., Rubin, J., Han, W., Venge, P., & Xu, S. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00980110 · Cited by 295
“The assays are based on different formats and include RIA (20), Western blotting (21), ELISA (22,23), Triage device (24), and the Architect platform (16).”
MethodNeutrophil gelatinase‐associated lipocalin: pathophysiology and clinical applications
Singer, E., Markó, L., Paragas, N., Barasch, J., Dragun, D., Müller, D. N., Budde, K., & Schmidt‐Ott, K. M. (2013) · Acta Physiologica · doi:10.1111/apha.12054 · Cited by 282
“In children undergoing cardiopulmonary bypass, NGAL measurements in urine and blood showed remarkable promise in identifying patients at risk of AKI early (Bennett et al. 2008; Mishra et al. 2005; Dent et al. 2007).”
BackgroundSelf-citationBiomarkers of acute kidney injury: the pathway from discovery to clinical adoption
Kashani, K., Cheungpasitporn, W., & Ronco, C. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0973 · Cited by 289
“Its performance has been evaluated in various settings, such as for prediction of AKI in pediatric [22] and adult cardiac surgery patients [72, 76], in critically ill patients [8, 24], in patients in the emergency department [20, 21], and in patients in the kidney transplant setting [77– 79].”
MethodHaase-Fielitz, A., Haase, M., & Devarajan, P. (2014) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563214521795 · Cited by 272
“High correlation between research ELISA’s and the Triage NGAL device has been reported.(55) The Abbott ARCHITECT analyser can process large numbers of samples and this urine NGAL assay proved to be precise and reproducible including between days and between reagent lots.”
MethodResultSelf-citationBiomarkers of Acute Kidney Injury
Edelstein, C. L. (2008) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2008.04.003 · Cited by 272
“In addition, the 2-hour postoperative NGAL levels correlated with duration of AKI and length of hospital stay, while the 12-hour NGAL level correlated strongly with mortality [17].”
Backgroundde Geus, H. R. H., Bakker, J., Lesaffre, E. M. E. H., & le Noble, J. L. M. L. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200908-1214oc · Cited by 269
Biological Markers of Acute Kidney Injury
Siew, E. D., Ware, L. B., & Ikizler, T. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080796 · Cited by 266
Maisel, A. S., Mueller, C., Fitzgerald, R., Brikhan, R., Hiestand, B. C., Iqbal, N., Clopton, P., & van Veldhuisen, D. J. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr087 · Cited by 248
Haase, M., Bellomo, R., & Haase-Fielitz, A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.046 · Cited by 244
“Sensitiv Mishra et al. (2005) (11)* 70.0 (45.7– Mishra et al. (2005) (11)† 100.0 (80.0– Wagener et al. (2006) (27) 68.8 (41.5– Dent et al. (2007) (28) 84.4 (69.9– Wagener et al. (2008) (29) 64.7 (52.1– Bennett et al. (2008) (30) 78.8 (69.2– Xin et al. (2008) (31) 76.9 (46.0– Koyner et al. (2008)…”
InfluentialEr, F., Nia, A. M., Dopp, H., Hellmich, M., Dahlem, K. M., Caglayan, E., Kubacki, T., Benzing, T., Erdmann, E., Burst, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.096370 · Cited by 239
NGAL: a biomarker of acute kidney injury and other systemic conditions
Soni, S. S., Cruz, D., Bobek, I., Chionh, C. Y., Nalesso, F., Lentini, P., de Cal, M., Corradi, V., Virzi, G., & Ronco, C. (2010) · International Urology and Nephrology · doi:10.1007/s11255-009-9608-z · Cited by 230
“Its clinical application was later validated in a study of 120 patients undergoing cardiopulmonary bypass (CPB) [ 28 ].”
Er, F., Nia, A. M., & Dopp, H. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2012.12.013 · Cited by 219
Krawczeski, C. D., Woo, J. G., Wang, Y., Bennett, M. R., Ma, Q., & Devarajan, P. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.12.057 · Cited by 208
Self-citationSerum and Urinary Biomarkers of Acute Kidney Injury
Lisowska-Myjak, B. (2010) · Blood Purification · doi:10.1159/000309421 · Cited by 200
“The devastating course of AKI explains the growing interest of clinicians in effective protection against the consequences of the disease, based upon its early detection and assessment of the clinical course and prognosis, allowing institution of effective treatment [ , , , , , ,”
BackgroundCardiopulmonary Bypass–associated Acute Kidney Injury
Kumar, A. B., Suneja, M., & Riou, B. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318210f86a · Cited by 199
Biomarkers in acute and chronic kidney disease
Nickolas, T. L., Barasch, J., & Devarajan, P. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f4e525 · Cited by 200
Self-citationZimmerman, R. F., Ezeanuna, P. U., Kane, J. C., Cleland, C. D., Kempananjappa, T. J., Lucas, F. L., & Kramer, R. S. (2011) · Kidney International · doi:10.1038/ki.2011.156 · Cited by 198
McIlroy, D. R., Wagener, G., & Lee, H. T. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04240609 · Cited by 190
Novel Biomarkers Early Predict the Severity of Acute Kidney Injury After Cardiac Surgery in Adults
Haase, M., Bellomo, R., Devarajan, P., Ma, Q., Bennett, M. R., Möckel, M., Matalanis, G., Dragun, D., & Haase-Fielitz, A. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.04.023 · Cited by 189
Self-citationClerico, A., Galli, C., Fortunato, A., & Ronco, C. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2011-0814 · Cited by 169
“A point-of-care test (POCT) method (Triage ® Bioste, Alere Health) is a commercial fl uorescencebased immunoassay for a rapid measurement (approximately 30 min) of NGAL in EDTA anti-coagulated whole blood or plasma samples (21, 29, 30) .”
BackgroundMethodEarly Diagnosis of Acute Kidney Injury: The Promise of Novel Biomarkers
Soni, S. S., Ronco, C., Katz, N., & Cruz, D. N. (2009) · Blood Purification · doi:10.1159/000227785 · Cited by 166
“have found uNGAL as an early marker of AKI in critically ill polytrauma patients. Many other studies have found NGAL to be a reliable early biomarker for AKI [”
Moniaux, N., Chakraborty, S., Yalniz, M., Gonzalez, J., Shostrom, V. K., Standop, J., Lele, S. M., Ouellette, M., Pour, P. M., Sasson, A. R., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604329 · Cited by 164
“Serum NGAL measurement has been shown in studies to be elevated early in acute renal injury (Mishra et al, 2005; Dent et al, 2007) and in patients with borderline tumours of the ovary (Lim et al, 2007).”
the Assessment Serial Evaluation, A. S. S. O. A. K. I. (.-A. S. I., Go, A. S., Parikh, C. R., Ikizler, T. A., Coca, S., Siew, E. D., Chinchilli, V. M., Hsu, C.-Y., Garg, A. X., Zappitelli, M., et al. (2010) · BMC Nephrology · doi:10.1186/1471-2369-11-22 · Cited by 163
“This set will include urine biomarkers (IL-18, [26] NGAL, [27] KIM-1, [28] cystatin C, [29] L-FABP [30] and NAG [31]) and blood biomarkers (serum cystatin C, [32] serum NGAL [33] and plasma IL-6 [34]).”
MethodSelf-citationSrisawat, N., on behalf of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Investigators, Murugan, R., Lee, M., Kong, L., Carter, M., Angus, D. C., & Kellum, J. A. (2011) · Kidney International · doi:10.1038/ki.2011.160 · Cited by 159
“RESULTS Participant characteristics and hospital course by recovery Of the 1836 subjects with community-acquired pneumonia, 631 developed AKI.32 We selected a subset of 189 patients (30”
InfluentialConstantin, J., Futier, E., Perbet, S., Roszyk, L., Lautrette, A., Gillart, T., Guérin, R., Jabaudon, M., Souweine, B., Bazin, J.-É., et al. (2009) · Journal of Critical Care · doi:10.1016/j.jcrc.2009.05.010 · Cited by 160
“A cutoff value of 150 pg/mL was used to separate normal from higher values [5].”
BackgroundMethodInfluentialα-Intercalated cells defend the urinary system from bacterial infection.
Paragas, N., Kulkarni, R., Werth, M., Schmidt-Ott, K., Forster, C., Deng, R., Zhang, Q.-Y., Singer, E., Klose, A., Shen, T.-H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71630 · Cited by 150
“Inductive stimuli included sepsis (10–14), ischemia-reperfusion injury (IR) (9, 15–27), obstructive uropathy (28), nephrotoxins (15, 29–33), trauma-rhabdomyolysis (34), kidney graft injury (35, 36), or a mixture of these maladies (37, 38).”
Self-citationPerioperative acute kidney injury: risk factors, recognition, management, and outcomes
Borthwick, E. M., & Ferguson, A. J. (2010) · BMJ · doi:10.1136/bmj.c3365 · Cited by 156
Haase‐Fielitz, A., Bellomo, R., Devarajan, P., Bennett, M., Story, D., Matalanis, G. S., Frei, U. A., Dragun, D., & Haase, M. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp234 · Cited by 157
Self-citationNeutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury
Devarajan, P. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn531 · Cited by 164
Self-citationCystatin C as a Marker of Acute Kidney Injury in the Emergency Department
Soto, K., Coelho, S., Rodrigues, B., Martins, H., Frade, F., Lopes, S., Cunha, L., Papoila, A. L., & Devarajan, P. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00690110 · Cited by 150
Self-citationRuf, B., Bonelli, V., Balling, G., Hörer, J., Nagdyman, N., Braun, S., Ewert, P., & Reiter, K. (2015) · Critical Care · doi:10.1186/s13054-015-0760-9 · Cited by 146
“We noted that in earlier studies [36-39], CPB time differed significantly between AKI and non-AKI groups, which was not the case in our study.”
Kümpers, P., Hafer, C., Lukasz, A. H., Lichtinghagen, R., Brand, K., Fliser, D., Faulhaber‐Walter, R., & Kielstein, J. T. (2010) · Critical Care · doi:10.1186/cc8861 · Cited by 140
“However, to date, there is no conclusive evidence for urine NGAL being superior to plasma NGAL [17,18,20,36,37].”
BackgroundZhou, F., Luo, Q., Wang, L., & Han, L. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezv199 · Cited by 136
“1 81 16 A peak postoperative increase in SCr ≥50% compared with preoperative Dent (2007) [29] USA PC Children 4.”
BackgroundAskenazi, D. J., Koralkar, R., Levitan, E. B., Goldstein, S. L., Devarajan, P., Khandrika, S., Mehta, R. L., & Ambalavanan, N. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e3182275164 · Cited by 133
“Development of these biomarkers has advanced such that point-of-care biomarker assessment kits are now becoming available for serum and urine NGAL (7,19) and KIM-1 (26).”
Self-citationAcute Kidney Injury in Children and Its Potential Consequences in Adulthood
Goldstein, S. L. (2012) · Blood Purification · doi:10.1159/000334143 · Cited by 131
Shapiro, N. I., Trzeciak, S., Hollander, J. E., Birkhahn, R., Otero, R., Osborn, T. M., Moretti, E., Nguyen, H. B., Gunnerson, K. J., MILZMAN, D. P., et al. (2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.02.010 · Cited by 132
Kinetic eGFR and Novel AKI Biomarkers to Predict Renal Recovery
Dewitte, A., Joannès-Boyau, O., Sidobre, C., Fleureau, C., Bats, M., Derache, P., Leuillet, S., Ripoche, J., Combe, C., & Ouattara, A. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12651214 · Cited by 134
“Blood samples for plasma NGALwere collected in EDTA anticoagulated tubes and were immediately analyzed using the Triage NGAL test (Alere, San Diego, CA) (15).”
MethodValidation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury after Pediatric Cardiac Surgery
Meersch, M., Schmidt, C. G., Aken, H. V., Rossaint, J., Görlich, D., Stege, D., Malec, E. J., Januszewska, K., & Zarbock, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110865 · Cited by 134
“Acute kidney injury (AKI) is a common complication of pediatric cardiac surgery and negatively impacts short- and longterm outcomes [1–3].”
BackgroundEmerging urinary biomarkers in the diagnosis of acute kidney injury
Devarajan, P. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.4.387 · Cited by 139
Self-citationThe ischemic/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice
Andreucci, M., Faga, T., Pisani, A., Perticone, M., & Michael, A. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.12.001 · Cited by 124
The Role of Biomarkers in Acute Kidney Injury
Srisawat, N., & Kellum, J. A. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2019.08.010 · Cited by 143
Alvelos, M., Pimentel, R., Pinho, E., Gomes, A., Lourenço, P., Teles, M. J., Almeida, P., Guimarães, J. T., & Bettencourt, P. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06140710 · Cited by 120
“The performance of NGAL in acute kidney dysfunction prediction has varied widely across studies, probably because different definitions of acute kidney injury have been used (10,18,19).”
MethodBasu, R. K., Andrews, A. L., Krawczeski, C. D., Manning, P. B., Wheeler, D. S., & Goldstein, S. L. (2013) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3182772f61 · Cited by 124
“Dent et al (9) 2007 120 38 NR NR 99 6 NR NR 143 13”
InfluentialMamikonian, L. S., Mamo, L. B., Smith, P. B., Koo, J., Lodge, A. J., & Turi, J. L. (2014) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000047 · Cited by 116
Biomarkers for the Diagnosis of Acute Kidney Injury
Waikar, S. S., & Bonventre, J. V. (2008) · Nephron Clinical Practice · doi:10.1159/000142928 · Cited by 115
“prospectively obtained serial urine and serum samples from 71 children undergoing cardiopulmonary bypass for surgical correction of congenital heart disease. Twenty children developed AKI, defined as a 50p increase in SCr. Urinary NGAL at just 2 h following CPB almost perfectly predicted which patients would go on to…”
InfluentialNovel Biomarkers of Heart Failure
Savic-Radojevic, A. R., Pljesa-Ercegovac, M. S., Matic, M., Simic, D., Radovanović, S., & Simic, T. P. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.09.002 · Cited by 127
Urinary Netrin-1 Is an Early Predictive Biomarker of Acute Kidney Injury after Cardiac Surgery
Ramesh, G., Krawczeski, C. D., Woo, J. G., Wang, Y., & Devarajan, P. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05140709 · Cited by 112
Self-citationHollmén, M., Kyllönen, L., Inkinen, K. A., Lällä, M., & Salmela, K. T. (2010) · Kidney International · doi:10.1038/ki.2010.351 · Cited by 111
A long journey for acute kidney injury biomarkers
Oh, D.-J. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1721300 · Cited by 119
“Subsequently, multiple studies have confirmed the predictive ability of NGAL in the pediatric CPB context [31,32].”
BackgroundWagener, G., Minhaz, M., Mattis, F. A., Kim, M., Emond, J. C., & Lee, H. T. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq770 · Cited by 110
“Methods to standardize the detection of NGAL detection and create clinical platforms that allow rapid and reliable detection of NGAL in the blood [24] or urine [25] are currently being evaluated.”
MethodParikh, C. R., Lu, J. C., Coca, S. G., & Devarajan, P. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010076 · Cited by 104
Self-citationAdvances in the study of subclinical AKI biomarkers
Zou, C., Wang, C.-T., & Lu, L. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.960059 · Cited by 92
Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application
Al‐Ismaili, Z., Palijan, A., & Zappitelli, M. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1576-0 · Cited by 103
“NGAL assays and has demonstrated a strong association of NGAL with outcomes such as length of stay, dialysis requirement, and mortality [24, 25].”
Hornik, C. P. V., He, X., Jacobs, J. P., Li, J. S., Jaquiss, R. D. B., Jacobs, M. L., O’Brien, S. M., Peterson, E. D., & Pasquali, S. K. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.05.100 · Cited by 109
“In a study of 120 children undergoing cardiopulmonary bypass, acute kidney injury of any severity was associated with significantly increased mortality and longer length of stay compared with those who have normal renal function after surgery [17].”
The Use of Targeted Biomarkers for Chronic Kidney Disease
Devarajan, P. (2010) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2010.09.002 · Cited by 102
“The deployment of standardized clinical platforms for the rapid and accurate measurement of NGAL in urine (33) and plasma (34) has further facilitated the widespread use and validation of NGAL as a biomarker.”
MethodSelf-citationMałyszko, J., Bachórzewska-Gajewska, H., Poniatowski, B., Małyszko, J. S., & Dobrzycki, S. (2009) · Renal Failure · doi:10.3109/08860220903216113 · Cited by 100
Portal, A., Mcphail, M., Bruce, M., Coltart, I., Slack, A., Sherwood, R., Heaton, N., Shawcross, D., Wendon, J., & Heneghan, M. (2010) · Liver transplantation · doi:10.1002/lt.22158 · Cited by 92
“302 Bilirubin (lmol/L) 59 (32-89) 74 (47-94) 42 (25-78) 0.”
Kilburn, D., Shekar, K., & Fraser, J. F. (2016) · BioMed Research International · doi:10.1155/2016/1094296 · Cited by 99
Poniatowski, B., Małyszko, J., Bachórzewska-Gajewska, H., Małyszko, J. S., & Dobrzycki, S. (2009) · Kidney & Blood Pressure Research · doi:10.1159/000208989 · Cited by 102
Comparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury
Schley, G., Köberle, C., Manuilova, E., Rutz, S., Förster, C., Weyand, M., Formentini, I., Kientsch-Engel, R., Eckardt, K., & Willam, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145042 · Cited by 107
Moore, E., Bellomo, R., & Nichol, A. D. (2010) · PubMed · Cited by 94
Perry, T. E., Muehlschlegel, J. D., Liu, K.-Y., Fox, A. A., Collard, C. D., Shernan, S. K., & Body, S. C. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181da938e · Cited by 93
“tor of AKI in both pediatric and adult cardiac surgical cohorts.(11,13,17,18) Although some authors have stipulated that an increase in postoperative serum creatinine levels”
BackgroundMethodInfluentialUrinary biomarkers to detect acute kidney injury in the pediatric emergency center
Du, Y., Zappitelli, M., Mian, A. I., BENNETT, M. R., Ma, Q., Devarajan, P., Mehta, R. L., & Goldstein, S. L. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1673-0 · Cited by 91
“In fact, recent work has demonstrated the feasibility and clinical utility of developing rapid urine [34] and plasma NGAL [35] assays as well as a urine dipstick for KIM-1 [36].”
Self-citationAcute kidney injury in childhood: should we be worried about progression to CKD?
Goldstein, S. L., & Devarajan, P. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1653-4 · Cited by 90
“The deployment of standardized clinical platforms for the rapid and accurate measurement of NGAL in urine [14] and plasma [13] has further facilitated the widespread use and validation of NGAL as a biomarker.”
MethodSelf-citationAn update and review of acute kidney injury in pediatrics
Basu, R. K., Devarajan, P., Wong, H. R., & Wheeler, D. S. (2010) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181fe2e0b · Cited by 89
“3%) Dent et al (112) 2007 After CPB 120 4.”
Self-citationDevarajan, P., Krawczeski, C. D., Nguyen, M. T. P., Kathman, T., Wang, Z., & Parikh, C. R. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.04.014 · Cited by 87
“The type of surgical procedures performed was similar to that previously reported in studies performed by our group (12,13).”
ResultSelf-citationAcute kidney injury following acute pancreatitis: A review
Petejová, N., & Martínek, A. (2013) · Biomedical Papers · doi:10.5507/bp.2013.048 · Cited by 100
NGAL in Acute Kidney Injury: From Serendipity to Utility
Devarajan, P. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.07.008 · Cited by 85
Self-citationBiomarkers for the diagnosis of acute kidney injury
Waikar, S. S., & Bonventre, J. V. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f08745 · Cited by 85
Lee, Y., Hu, Y.-Y., Lin, Y.-S., Chang, C., Lin, F., Wong, M., Hsu, K.-H., & Hsu, W. (2012) · BMC Veterinary Research · doi:10.1186/1746-6148-8-248 · Cited by 85
“Noticeably, the 2 h urine NGAL level has been found to be an effective biomarker for the prediction of AKI in several human medical studies [12-14].”
BackgroundResultUpdate on Biomarkers of Acute Kidney Injury
Schiffl, H., & Lang, S. M. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/bf03262209 · Cited by 85
Somma, S. D., Magrini, L., Berardinis, B. D., Marino, R., Ferri, E., Moscatelli, P., Ballarino, P., Carpinteri, G., Noto, P., Gliozzo, B., et al. (2013) · Critical Care · doi:10.1186/cc12510 · Cited by 88
“Still others have used a cutoff value of 170 ng/ml, demonstrating that NGAL predicts 48 to 72 hour development of type 1 cardiorenal syndrome with NPV of 100% and PPV of 50% [18,38,42,43].”
BackgroundMethodRole of New Biomarkers: Functional and Structural Damage
Tsigou, E., Psallida, V., Demponeras, C., Boutzouka, E., & Baltopoulos, G. (2013) · Critical Care Research and Practice · doi:10.1155/2013/361078 · Cited by 83
“also found an excellent performance of plasma NGAL, at a cutoff value of 150 ng/mL in pediatric cardiac surgery population [11].”
BackgroundPerioperative acute kidney injury
Calvert, S., & Shaw, A. (2012) · Perioperative Medicine · doi:10.1186/2047-0525-1-6 · Cited by 94
“Importantly, many studies to date have excluded patients with CKD, who have been consistently demonstrated to be at high risk for AKI in the perioperative period [20] and these biomarkers must therefore first be characterized over a range of baseline values, with more information required to identify and explain clini…”
BackgroundInfluentialUpdate on acute kidney injury after cardiac surgery
Shaw, A. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.08.054 · Cited by 81
Axelrod, D. M., Sutherland, S. M., Anglemyer, A. T., Grimm, P. C., & Roth, S. J. (2015) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000612 · Cited by 81
“We estimated a 35% prevalence of AKI in this population based on the existing literature (2, 4, 10, 11).”
Method
Metadata
- Authors
- Dent, C. L., Ma, Q., Dastrala, S., Bennett, M., Mitsnefes, M. M., Barasch, J., & Devarajan, P.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Columbia University (US)
- Corresponding author
- Devarajan, Prasad
- Venue
- Critical Care
- Published
- 2007-12-10
- Volume
- 11
- Issue
- 6
- Pages
- R127-R127
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2246223
- OpenAlex
- W2035397803
- Cited by
- 483
- References
- 33
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 13 · 2022: 11 · 2021: 18 · 2020: 8 · 2019: 15 · 2018: 18 · 2017: 20 · 2016: 36 · 2015: 46 · 2014: 43 · 2013: 47 · 2012: 49
- FWCI
- 22.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Cincinnati Children's Hospital Medical Center
- National Institutes of Health (DK52612)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK070163, P50DK052612, R01DK053289)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- neutrophil gelatinase-associated lipocalin, acute kidney injury, pediatric cardiac surgery, cardiopulmonary bypass, point-of-care biomarkers, early prediction of AKI, serum creatinine, postoperative morbidity and mortality, length of hospital stay, renal function monitoring, pediatric congenital heart disease, postoperative renal complications, biomarker validation
- MeSH terms
- Lipocalin-2, Acute-Phase Proteins, Child, Child, Preschool, Cross-Sectional Studies, Female, Cardiac Surgical Procedures, Humans, Male, Morbidity, Mortality, Pilot Projects, Predictive Value of Tests, Prospective Studies, Proto-Oncogene Proteins, Cohort Studies, Biomarkers, Point-of-Care Systems, Lipocalins, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.